Anticancer Activity Assay of Some Purification Compounds Extracted from Pleurotus Ostreatus

Authors

  • Suhad M. Aljubori Department of Biology, Faculty of Science, University of Kufa, Najaf, Iraq Author
  • Mohammed M. Alrufae Department of Biology, Faculty of Science, University of Kufa, Najaf, Iraq Author
  • Hamid N. Alkelabi Faculty of Medicine, University of Babylon, Babylon, Iraq. Author

DOI:

https://doi.org/10.61841/m8e3j944

Keywords:

Pleurotus Ostreatus, Analytical and Preparative HPLC Technique, Anticancer, (C.V) Cytotoxicity Assay, IC50, GC-MS

Abstract

The present study is designed to evaluate some compounds extracted from Pleurotus ostreatus and purified using analytical and preparative HPLC techniques, then tested the anticancer activity by in vitro crystal violet (C.V) cytotoxicity assay on cancer and normal cell lines; chemical descriptions of these compounds were done by GC-MS technique. Analytical and preparative HPLC carried out with a 25% methanol with 1% formic acid mobile phase and description of about 12 fractions with retention times (9, 10, 11.5, 12, 12.5, 13.5, 14.7, 15.5, 17, 18, 19.5-21,21.8) at 254 nm, respectively. In vitro C.V. cytotoxicity assay on SW-480 colon cancer cell line appeared to have excellent inhibition with (1, 5, 6, 7, 12) fractions with (1000, 500, 250, 125, 62.5 μg/ml), while the same fractions have no effect on the Vero-101 normal cell line. GC-MS analysis data gave us the most probable anticancer compounds in these fractions, such as quinoline, 1H indole, silane compounds, and N-hexadecanoic acid. 

Downloads

Download data is not yet available.

References

[1] Ruddon, R.W. (2007). Cancer biology, 4th ed. Oxford University Press, USA.

[2] NCI, (2011). National Cancer Institute. Cancer topics http://www.cancer.

gov/cancertopics/cancerlibrary/what-is-cancer

[3] Anand, P.; Kunnumakara, A. B.; Sundaram, C.; Harikumar, K. B.; Tharakan, S. T.; Lai, O. S.

Aggarwal, B. B. (2008). Cancer is a preventable disease that requires major lifestyle

changes. Pharmaceutical research, 25(9), 2097-2116.‏

[4] WHO (2011). World Health Organization. www.who.int/mediacentre/events/annual/world_cancer_day.

[5] Zaidman, B.Z.; B.Z.;Yassin, M.; Mahajna, J.; and Wasser, S.P. (2005). Medicinal mushroom modulators of

molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67:453–468

[6] Leung, M.Y.K.; Liu, C.; Koon, J.C.M.; and Fung, K.P. (2006). Polysaccharide biological response

modifiers. Immunol Lett 105:101–111.

[7] Wasser, P. and Weis, L. (1999) Medicinal Properties of Substances Occurring in Higher Basidiomycetes

Mushrooms: Current Perspectives. International Journal of Medicinal Mushrooms, 1, 31-62.

[8] Lucas EH, Montesono R, Pepper MS MS,(1957). Tumor inhibitors in Boletus edulis and other

holobasidiomycetes. Antibiot Chemother; 7: 1−4.

[9] Kim, M.; Suh, H.; Cho, E.J. and Buratowski, S. (2009) Phosphorylation of the yeast Rpb1 C-terminal

domain at serines 2, 5, and 7. J Biol Chem 284(39):26421-6

[10] Daba, A.S.; Wissa, J.E.; Esmat, A.Y.; Rashad, M. and Fatta,h A. (2002) Antitumor activity of

polysaccharides from Pleurotus ostreatus fruiting bodies and mycelia cultivated on date waste media

Egyptian J. Biochem. Mol. Biol. (In Press)

[11] Andrej, J. and Daniel, A. (2008). Pleurotus ostreatus inhibits proliferation of human breast and colon cancer

cells through p53-dependent as well as p53-independent pathway International Journal of Oncology, 33:

1307-1313,

[12] Berk, Z. (2013). Food process engineering and technology. Academic Press.‏

[13] Freshney, R.I. (1994). Culture of Animal Cells. 3rd ed. Wiley-Liss. USA. Pp. 267-308.

[14] Priya, V., Jananie, R. K., & Vijayalakshmi, K. (2012). GC/MS determination of bioactive components of

Pleurotus ostreatus. International Research Journal of Pharmacy, 3(3), 150-151.

[15] Kazakevich, Y. V., and Lobrutto, R. (2007). HPLC for pharmaceutical scientists. ohn ile an ons

[16] Tong, H.; Xia, F.; Feng, K.; Sun, G.; Gao, X.; Sun, L.; and Sun, X. (2009). Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus. Bioresource Technology, 100(4), 1682-1686.

[17] Lee, J. S., and Hong, E. K. (2011). Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. International immunopharmacology, 11(9), 1226-1233.

[18] Zusman, I.; Reifen, R.; Livni, O.; Smirnoff, P.; Gurevich, P.; Sandler, B.; and Madar, Z. (1997). Role of apoptosis, proliferating cell nuclear antigen, and p53 protein in chemically induced colon cancer in rats fed corncob fiber treated with the fungus Pleurotus ostreatus. Anticancer research, 17(3C), 2105-2113.

[19] Afzal, O.; Kumar, S.; Haider, M. R.; Ali, M. R.; Kumar, R.; Jaggi, M.; and Bawa, S. (2015). A review on

anticancer potential of bioactive heterocycle quinoline. European journal of medicinal chemistry, 97, 871-

910.

[20] Premanathan, M.; Radhakrishnan, S.; Kulangiappar, K.; Singaravelu, G.; Thirumalaiarasu, V.; Sivakumar, T.; and Kathiresan, K. (2012). Antioxidant and anticancer activities of isatin (1H-indole-2, 3-dione), isolated from the flowers of Couroupitaguianensis Aubl. The Indian Journal of Medical Research, 136(5), 822.

[21] Biswal, S., Sahoo, U., Sethy, S., Kumar, H. K. S., & Banerjee, M. (2012). Indole: the molecule of diverse biological activities. Asian J. Pharm. Clin. Res., 5(1), 1-6.

[22] Lokesh, R., Manasvi, V., and Praveena, L. B. (2016). Antibacterial and antioxidant activity of saponin from Abutilonindicum leaves. Asian J Pharm Clin Res, 9(3), 344-347.

Downloads

Published

31.07.2020

How to Cite

M. Aljubori, S., M. Alrufae, M., & N. Alkelabi, H. (2020). Anticancer Activity Assay of Some Purification Compounds Extracted from Pleurotus Ostreatus. International Journal of Psychosocial Rehabilitation, 24(5), 1177-1188. https://doi.org/10.61841/m8e3j944